- Home
- SKIN vs PCF Comparison
SKIN vs PCF Comparison
Compare SKIN & PCF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SKIN | PCF |
|---|---|---|
| Founded | 1997 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 123.9M | 113.0M |
| IPO Year | 2020 | 1994 |
Fundamental Metrics
Financial Performance| Metric | SKIN | PCF |
|---|---|---|
| Price | $0.82 | $5.47 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $2.03 | N/A |
| AVG Volume (30 Days) | ★ 750.6K | 94.4K |
| Earning Date | 03-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 55.56 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $300,790,000.00 | N/A |
| Revenue This Year | $1.24 | N/A |
| Revenue Next Year | $4.73 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.78 | $5.36 |
| 52 Week High | $2.69 | $6.65 |
Technical Indicators
Market Signals| Indicator | SKIN | PCF |
|---|---|---|
| Relative Strength Index (RSI) | 30.10 | 29.26 |
| Support Level | N/A | $5.36 |
| Resistance Level | $1.61 | $6.47 |
| Average True Range (ATR) | 0.10 | 0.08 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 2.62 | 22.45 |
Price Performance
Historical ComparisonAbout SKIN The Beauty Health Company
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.
About PCF High Income Securities Fund
High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective mainly by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.